The company has announced a board meeting to approve the financial results for the quarter and half-year.

A significant agenda item is the consideration and approval of fund-raising.

This could involve issuing Equity Shares, Convertible Warrants, or other instruments.

Potential methods include Preferential Issue, Rights Issue, or Qualified Institutional Placement (QIP), possibly in multiple tranches.

This strategic move is crucial for the company's financial health, enabling future growth and operational stability, which directly impacts stakeholder value through potential capital infusion.